Monteverde & Associates investigates AtaiBeckley sale to Eli Lilly

The law firm says AtaiBeckley shareholders are set to receive $6.75 a share in cash plus up to $2.50 per share through a contingent value right tied to BPL-003 and VLS-01 milestones.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.